trilaciclib Vials, lyophilized injection 100 mg, 300 mg
Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, China
Manufacturer #39090
Clinical-stage pharmaceutical company focused on oncology, neuroscience, and autoimmune diseases. Develops innovative and generic medicines with growing global ambitions. Strategy includes partnerships and selective international expansion.